Literature DB >> 29631512

Infections in hospitalized lupus nephritis patients: characteristics, risk factors, and outcomes.

P Liu1, H Z Tan1, H Li2, C C Lim1, J C J Choo1.   

Abstract

Background There are limited studies documenting infection epidemiology in lupus nephritis (LN) patients. We aimed to study infection incidences and risk characteristics and ascertain possible predictors of infective outcomes in a multiethnic Asian population. Methods This retrospective study from 2006 to 2012 included newly diagnosed LN patients. We collected admissions, immunosuppression, and infection data until end-stage renal failure, death, last follow-up, or the year 2015. The infection incidence rates were evaluated and a generalized linear latent and mixed models (GLLAMM) analysis was carried out to evaluate potential predictors of infection. Results Our cohort of 101 patients consisted of mainly Chinese (75.2%), females (78.2%), and a median age of 38 years (IQR 26-49). The median time of follow-up was 72.8 months (IQR 49.5-94.0). Six out of 14 patient deaths were infection related. Seventy-eight out of 200 admissions, with a total of 102 episodes of infection, occurred in 46 patients. The incidence of infection rates leading to admissions was 10.3 per 100 person-years and the incidence of infection episodes rates was 17.6 per 100 person-years. Cytomegalovirus (CMV) was the most common organism identified. Univariate GLLAMM analysis showed Malay compared to Chinese ethnicity (HR 2.833 (95% CI 1.088-7.373)), use of oral cyclophosphamide (HR 6.618 (95% CI 1.015-43.154)) and rituximab (HR 3.967 (95% CI 1.157-13.603)) as predictors of infection-related admissions. Malay ethnicity and rituximab remained significant in the multivariate GLLAMM analysis. Conclusions Our study highlights substantial infection incidences in patients with LN and its contribution to deaths.

Entities:  

Keywords:  Infection; hospitalization; lupus; lupus nephritis; systemic lupus erythematosus

Mesh:

Substances:

Year:  2018        PMID: 29631512     DOI: 10.1177/0961203318768881

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  6 in total

1.  Infection mitigation a necessity in lupus patients.

Authors:  Peiyun Liu; Hui Zhuan Tan; Huihua Li; Jason Chon Jun Choo; Cynthia Ciwei Lim
Journal:  Clin Rheumatol       Date:  2018-10-23       Impact factor: 2.980

2.  Infection-related hospitalization after intensive immunosuppressive therapy among lupus nephritis and ANCA glomerulonephritis patients.

Authors:  Peihong Yin; Jianbo Li; Qiong Wen; Yagui Qiu; Wenyi Liang; Junxian Wang; Jing Yu; Zhong Zhong; Xiao Yang; Xueqing Yu; Qing Ye; Fengxian Huang
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

3.  Mortality risk prediction in lupus patients complicated with invasive infection in the emergency department: LUPHAS score.

Authors:  Wanlong Wu; Jun Ma; Yuhong Zhou; Chao Tang; Feng Zhao; Fangfang Sun; Wenwen Xu; Jie Chen; Shuang Ye; Yi Chen
Journal:  Ther Adv Musculoskelet Dis       Date:  2019-11-05       Impact factor: 5.346

Review 4.  Bacterial infections in lupus: Roles in promoting immune activation and in pathogenesis of the disease.

Authors:  Michael Battaglia; Lee Ann Garrett-Sinha
Journal:  J Transl Autoimmun       Date:  2020-12-23

5.  Predisposing Factors of Tuberculosis Infection in Systemic Lupus Erythematosus Patients: A Single-Center Case-Control Study.

Authors:  Ivan Damara; Anna Ariane; Kevin Winston
Journal:  Cureus       Date:  2022-06-28

6.  Nocardiosis in glomerular disease patients with immunosuppressive therapy.

Authors:  Yuzhang Han; Zineng Huang; Huifang Zhang; Liyu He; Lin Sun; Yu Liu; Fuyou Liu; Li Xiao
Journal:  BMC Nephrol       Date:  2020-11-26       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.